SAFETY AND EFFICACY OF INTRAVENOUS MAGNESIUM SULFATE IN MODULATING CHANGES IN SYMPTOMS AND DIVALENT CATION LEVELS ASSOCIATED WITH FOSCAVIR THERAPY: A PHASE IV RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER, PILOT STUDY: